Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.

A new molecular imaging agent can accurately identify a crucial biomarker found among many different types of cancer ...

An pioneering new drug causes tiny cancer cells to glow during surgery. Ascension Saint Thomas Dr. John F. Lazar said: "It's ...

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical ...

The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...

Pending MRI deregulation is behind the now approved merger of Integral Diagnostics and Capitol Health, and analysts see significant opportunity ...

A Farncombe woman's cancer was identified within hours thanks to a new AI tool that has been introduced by the Royal Surrey ...

Precision medicine is an innovative approach that tailors treatment to the unique genetic and molecular characteristics of a ...

A deep learning radiomic biomarker has been developed and validated to predict responses to immune checkpoint inhibitors in ...

Shares in heart valve innovator Anteris Technologies (ASX:AVR) are trading on the US Nasdaq exchange after the pricing of its ...

Dr. Peter Jianrui Liu, CEO of Oxford Cancer Analytics, says the world should use machine learning-driven blood tests to ...